Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (2883)	11/19/1997 5:15:00 PM
From: Steve Fancy	Read Replies (1) of 6136

Izzy...I'll bet a lot of us are concerned. The stock will likely continue to trend downwards if the lack of news continues. There appear to be too many if's remaining to support the stock at these P/E levels. The supporting analysts have clammed up, other than internal documents released to sooth nervous investors, and the company dosen't release any news. If Austrailian approval has happened, or is about to happen, they should let investors know, along with expected inpact to the bottom line. I don't buy that '98 estimates include anything but US sales. Agoroun should clarify this. I will write them and ask. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next